MicroVention Announces First U.S. Patient Treated with FRED™ X™ Flow Diverter Featuring X Technology
/PRNewswire/ -- MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation...
Thomas Jefferson University Hospital United States Aliso Viejo Thomas Jefferson University Cathy Demyanovich Carsten Schroeder
Source: prnewswire.com